1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation : OPINION primary analysis
(
- Contribution to journal › Article
- 2019
-
Mark
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations
(
- Contribution to journal › Article
- 2017
-
Mark
Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation
(
- Contribution to journal › Article
- 2011
-
Mark
Tentative (id)entities: On technopolitical cultures and the experiencing of genetic testing
(
- Contribution to journal › Article
- 2004
-
Mark
External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years
(
- Contribution to journal › Article